2.13
Tscan Therapeutics Inc 주식(TCRX)의 최신 뉴스
How to forecast TScan Therapeutics Inc. trends using time series2025 Big Picture & Safe Entry Zone Identification - newser.com
Short interest data insights for TScan Therapeutics Inc.July 2025 Trends & Long-Term Capital Growth Strategies - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for TScan Therapeutics (NASDAQ:TCRX) - MarketBeat
TScan Therapeutics Inc. stock daily chart insightsJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Will TScan Therapeutics Inc. stock maintain momentum in 2025Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Will TScan Therapeutics Inc. stock continue dividend increasesWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
What the charts say about TScan Therapeutics Inc. today2025 Winners & Losers & AI Driven Stock Reports - newser.com
Is TScan Therapeutics Inc a good long term investmentSwing Trading Ideas & Fast Growing Capital Growth - earlytimes.in
Goldman Sachs Group Inc. Buys 9,676 Shares of TScan Therapeutics, Inc. $TCRX - Defense World
H.C. Wainwright Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Risk adjusted return profile for TScan Therapeutics Inc. analyzedTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Brokerages Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $7.80 - MarketBeat
How to build a custom watchlist for TScan Therapeutics Inc.July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
자본화:
|
볼륨(24시간):